SOURCE: Chembio Diagnostics, Inc.

November 02, 2005 09:15 ET

Chembio to Present at Upcoming Rodman & Renshaw 7th Annual Techvest Healthcare Conference on Monday, November 7th at 8:40 AM (EST)

MEDFORD, NY -- (MARKET WIRE) -- November 2, 2005 -- Chembio Diagnostics, Inc. (OTC BB: CEMI) announced that Larry Siebert, Chairman, President and CEO, will speak at the Rodman & Renshaw 7th Annual Techvest Healthcare Conference on Monday, November 7th at 8:40 AM (EST) in the New York Palace Hotel's Holmes I conference room in New York City, NY. This conference, to be held from November 7-9, 2005, will feature presentations from more than 290 public and privately held emerging growth healthcare companies on an array of topics including medical devices, cardiovascular disease, central nervous system disorders, infectious diseases and technology. The conference aims to provide presenting companies the opportunity to meet with institutional investors, corporate executives and experts from scientific and medical communities.

Mr. Siebert will review the company's progress towards FDA approval for its rapid HIV/AIDS tests and upcoming regulatory, marketing and operational milestones. Chembio's rapid HIV tests include the HIV 1/2 Stat-Pak™, HIV 1/2 Stat-Pak Dipstick™ and the HIV 1/2 Sure Check™. These tests are simple, safe, cost-effective and operator-friendly requiring less than five microliters of blood from a fingerstick.


Chembio Diagnostics, Inc. (Chembio) possesses expertise in the development and manufacturing of rapid test products for various infectious diseases, including HIV, Tuberculosis and Chagas Disease. References to Chembio Diagnostics, Inc. may actually refer to Chembio Diagnostic Systems, Inc., the 100%-owned subsidiary of Chembio Diagnostics, Inc. Chembio is located at 3661 Horseblock Road, Medford, NY 11763.

Contact Information